Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 9, 2006, Pages 3277-3282

  Chen, Hsiao Ling ^a   Yen, Chih Ching ^b,c   Lu, Chien Yu ^c   Yu, Chia Hen ^c   Chen, Chuan Mu ^c  

^a DA YEH UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial activity; Minimal bactericidal concentration (MBC); Minimal inhibitory concentration (MIC); Porcine lactoferricin; Synthetic peptide

Indexed keywords

ANTIINFECTIVE AGENT; LACTOFERRIN; PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; CANDIDA ALBICANS; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; SEQUENCE ALIGNMENT; STAPHYLOCOCCUS AUREUS; SWINE; SYNTHESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CATTLE; ESCHERICHIA COLI; HUMANS; LACTOFERRIN; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; SEQUENCE ALIGNMENT; STAPHYLOCOCCUS AUREUS; SWINE;

BACTERIA (MICROORGANISMS); BOVINAE; CANDIDA ALBICANS; ESCHERICHIA COLI; FUNGI; STAPHYLOCOCCUS AUREUS; SUIDAE;

EID: 33744454723     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf053031s     Document Type: Article

References (38)

1. Nuijens, J. H.; van Berkel, P. H. C.; Schanbacher, F. L. Structural and biological actions of lactoferrin. J. Mammary Gland Biol. Neoplasia 1996, 1, 285-295.
2. Brock, J. Lactoferrin: a multifunctional immunoregulatory protein. Immunol. Today 1995, 16, 417-419.
3. Tomita, M.; Wakabayashi, H.; Yamauchi, K.; Teraguchi, S.; Hayasawa, H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell Biol. 2002, 80, 109-112.
4. Appelmelk, B. J.; An, Y. Q.; Gerts, M.; Thijs, B. G.; De Boer, H. A.; Maclaren, D. M.; De Graaff, J.; Nuijens, J. H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 1994, 62, 2628-2632.
5. Emery, T. Iron deprivation as a biological defense mechanism. Nature 1980, 287, 776-777.
6. Ulvatne, H.; Haukland, H. H.; Olsvik, O.; Vorland, L. H. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett. 2001, 492, 62-65.
7. Crouch, S. P. M.; Slater, K. J.; Fletcher, J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992, 80, 235-240.
8. Tomita, M.; Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 1991, 74, 4137-4142.
9. Hwang, P. M.; Zhou, N.; Shan, X.; Arrowsmith, C. H.; Vogel, H. J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 1998, 37, 4288-4298.
10. Bellamy, W.; Takase, M.; Wakabayashi, H.; Kawase, K.; Tomita, M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73, 472-479.
11. Isamida, T.; Tanaka, T.; Omata, Y.; Yamauchi, K.; Shimazaki, K.; Saito, A. Protective effect of lactoferricin against Toxoplasma gondii infection in mice. J. Vet. Med. Sci. 1998, 60, 241-244.
12. Turchany, J. M.; Aley, S. B.; Gillin, F. D. Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun. 1995, 63, 4550-4552.
13. Yoo, Y. C.; Watanabe, S.; Watanabe, R.; Hata, K.; Shimazaki, K.; Azuma, I. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res. 1997, 88, 184-190.
14. Strom, M. B.; Haug, B. E.; Rekdal, O.; Skar, M. L.; Stensen, W.; Svendsen, J. S. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Biochem. Cell Biol. 2002, 80, 65-74.
15. Ulvatne, H.; Vorland, L. H. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli. Scand. J. Infect. Dis. 2001, 33, 507-511.
16. Schibli, D. J.; Hwang, P. M.; Vogel, H. J. The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 1999, 446, 213-217.
17. Chen, H. L.; Lai, Y. W.; Yen, C. C.; Lin, Y. Y.; Lu, C. Y.; Yang, S. H.; Tsai, T. C.; Lin, Y. J.; Lin, C. W.; Chen, C. M. Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris. J. Mol. Microbiol. Biotechnol. 2004, 8, 141-149.
18. Steijns, J. M.; van Hooijdonk, A. C. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br. J. Nutr. 2000, 84, S11-17.
19. Nibbering, P. H.; Ravensbergen, E.; Welling, M. M.; van Berkel, L. A.; van Berkel, P. H.; Pauwels, E. K.; Nuijens, J. H. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic- resistant bacteria. Infect. Immun. 2001, 69, 1469-1476.
20. Chu, R. M.; Wang, S. R.; Weng, C. N.; Pursel, V. G. Isolation and characterization of porcine milk lactoferrin. Am. J. Vet. Res. 1993, 54, 1154-1159.
21. Hanson, L. A.; Korotkova, M.; Haversen, L.; Mattsby-Baltzer, I.; Hahn-Zoric, M.; Silfverdal, S. A.; Strandvik, B.; Telemo. E. Breast-feeding, a complex support system for the offspring. Pediatr. Int. 2002, 44, 347-352.
22. Lee, W. J.; Farmer, J. L.; Hilty, M.; Kim, Y. B. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 1998, 66, 1421-1426.
23. Cheng, W. T. K.; Chen, B. C.; Chiou, S. T.; Chen, C. M. Use of nonautologous microencapsulated fibroblasts in growth hormone gene therapy to improve growth of midget swine. Hum. Gene Ther. 1998, 9, 1995-2003.
24. Vorland, L. H.; Ulvatne, H.; Andersen, J.; Haukland, H. H.; Rekdal, O.; Svendsen, J. S.; Gutteberg, T. J. Antibacterial effects of lactoferricin B. Scand. J. Infect. Dis. 1999, 31, 179-184.
25. van Winkelhoff, A. J.; Herrera, D.; Oteo, A.; Sanz, M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in the Netherlands and Spain. J. Clin. Periodontol. 2005, 32, 893-898.
26. Yamauchi, K.; Tomita, M.; Giehl, T. J.; Ellison, R. T., III. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 1993, 61, 719-728.
27. Hunter, H. N.; Demcoe, A. R.; Jenssen, H.; Gutteberg, T. J.; Vogel, H. J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 2005, 49, 3387-3395.
28. Schilling, O.; Vogel, A.; Kostelecky, B.; Natal da Luz, H.; Spemann, D.; Späth, B.; Marchfelder, A.; Tröger, W.; Meyer-Klaucke, W. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem. J. 2005, 385, 135-143.
29. Vorland, L. H.; Ulvatne, H.; Andersen, J.; Haukland, H.; Rekdal, O.; Svendsen, J. S.; Gutteberg, T. J. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand. J. Infect. Dis. 1998, 30, 513-517.
30. Chen, P. W.; Shyu, C. L.; Mao, F. C. Antibacterial activity of short hydrophobic and basic-rich peptides. Am. J. Vet. Res. 2003, 64, 1088-1092.
31. Strom, M. B.; Rekdal, O.; Svendsen, J. S. Antibacterial activity of 15-residue lactoferricin derivatives. J. Pept. Res. 2000, 56, 265-274.
32. Said-Salim, B.; Mathema, B.; Braughton, K.; Davis, S.; Sinsimer, D.; Eisner, W.; Likhoshvay, Y.; Deleo, F. R.; Kreiswirth, B. N. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J. Clin. Microbiol. 2005, 43, 3373-3379.
33. Murray, R. J.; Lim, T. T.; Pearson, J. C.; Grubb, W. B.; Lum, G. D. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia. Int. J. Infect. Dis. 2004, 8, 275-283.
34. Gorbach, S. L. Antimicrobial use in animal feed - time to stop. N. Engl. J. Med. 2001, 345, 1202-1203.
35. Van den Boogard, A. E.; Stobberingh. E. E. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 1999, 58, 589-607.
36. Wegener, H. C. Antibiotics in animal feed and their role in resistance development. Curr. Opin. Microbiol. 2003, 6, 439-445.
37. Boman, H. G. Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scand. J. Immunol. 1998, 48, 15-25.
38. Shai, Y.; Oren, Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001, 22, 1629-1641.